Delivery Order 75N98019D00058-75N91023F00001
Award Date
4/18/23
Potential Completion Date
8/22/23
Potential Value
$66K
Federal Agency
National Cancer Institute
Awardee
Societal Cdmo San Diego, LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
Q517 - Pharmacy Services
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $71,645.00, was issued by the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to Societal Cdmo San Diego, LLC, doing business as Irisys Inc. The contract is for the production of 4 mg AZA-TDC capsules for clinical use. Societal Cdmo San Diego is a contract development and manufacturing organization (CDMO) that specializes in pharmaceutical product development, manufacturing, and testing services for federal...
This is a delivery order awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services (HHS), to Societal CDMO San Diego, LLC, doing business as Irisys Inc. The contract is for the production of 2,000 capsules of 4 mg AZA-TDC, a drug compound for cancer research. The delivery order has a period of performance from March 4, 2019, to March 3, 2020, and a ceiling value of $89,481.00. The contract is a cost-plus-fixed-fee type and does not...
This is a federal contract award to Societal Cdmo San Diego, LLC (doing business as Irisys Inc.), a self-certified small disadvantaged business and contract development and manufacturing organization (CDMO). The $82,758 cost-plus-fixed-fee delivery order, awarded by the National Cancer Institute (NCI), is for the production of AZA-TD-CYD capsules for clinical use. The contract has no set-aside designation and is part of the $45 million Drug Formulation and Manufacturing Contracts 2019...
This federal contract award is for the manufacture of 1,600 hard gelatin capsules of TD-CYD at 10 mg strength under cGMP conditions for clinical use. The contract, valued at $85,762.00, was awarded to Societal CDMO San Diego, LLC (doing business as Irisys Inc.), a self-certified small disadvantaged business and limited liability company. The contract is a delivery order under the National Cancer Institute's (NCI) "Production of 10 mg TD-CYD Capsules for Clinical Use" program....
This federal contract award was issued by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to Societal CDMO San Diego, LLC (doing business as Irisys Inc.), a self-certified small disadvantaged business and contract development and manufacturing organization (CDMO). The $77,283 task order is for the manufacture of 4-thio-2-deoxycytidine capsules, which are likely being developed for use in...
This is a federal contract award to Societal CDMO San Diego, LLC (doing business as Irisys Inc.), a small disadvantaged business, to produce 1,000 vials of the drug Triapine (NSC-663249) for the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract is a Delivery Order with a cost plus fixed fee pricing type, has a ceiling value of $137,972.00, and an ultimate completion date of May 9, 2020....
This is a firm fixed-price delivery order issued by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Societal CDMO San Diego, LLC (a division of Recro Pharma, Inc.) for the production of 5,000 capsules of a 4 mg strength investigational cancer drug product, AZA-TDC, that is not commercially available. The contract has a total potential value of $153,336.00 and a completion date of March 31, 2024. It was awarded on November 19,...
The National Cancer Institute (NCI) awarded a $73,009 cost-plus-fixed-fee delivery order to Societal CDMO San Diego, LLC, a self-certified small disadvantaged business doing business as Irisys Inc. The contract is for the production of 600 bottles of tetrahydrouridine powder, a compound used in cancer research. This order is part of Societal CDMO San Diego's multiple-award $45 million Drug Formulation and Manufacturing Contracts 2019 Indefinite Delivery Vehicle (IDV) with the National Institutes...
This is a federal contract award issued by the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to Societal CDMO San Diego, LLC (doing business as Irisys Inc.), a self-certified small disadvantaged business. The $341,913.00 cost-plus-fixed-fee contract provides for the manufacture, qualification, and stability testing of TARP peptide and TWS-119 formulations to support the NCI's cancer research activities. This contract is issued under the...
This federal contract award is for Task Order 19: Z-Endoxifen HCL Capsules, with a ceiling value of $239,627.00. The contract was awarded on February 13, 2017 to Societal CDMO San Diego, LLC, doing business as Irisys Inc., a self-certified small disadvantaged business and limited liability company. The contract is a Delivery Order with a Cost Plus Fixed Fee pricing type, awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the Department...